tiprankstipranks
Prothena (PRTA)
NASDAQ:PRTA
US Market
Holding PRTA?
Track your performance easily

Prothena (PRTA) Technical Analysis

607 Followers

Technical Sentiment

Overall Consensus
Neutral
11Bullish
2Neutral
9Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Prothena’s (PRTA) Moving Averages Convergence Divergence (MACD) indicator is 0.26, suggesting Prothena is a Sell.
Prothena’s (PRTA) 20-Day exponential moving average is 14.54, while Prothena’s (PRTA) share price is $15.96, making it a Buy.
Prothena’s (PRTA) 50-Day exponential moving average is 14.92, while Prothena’s (PRTA) share price is $15.96, making it a Buy.

Prothena (PRTA) Pivot Points

Jan 29, 2025, 08:42 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
14.52
15.07
15.55
16.10
16.58
17.13
17.61
Fibonacci
15.07
15.46
15.70
16.10
16.49
16.73
17.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Prothena (PRTA) Moving Averages

Jan 29, 2025, 08:42 PM
Period
Simple
Exponential
MA5
15.51Buy
15.47Buy
MA10
14.45Buy
14.91Buy
MA20
14.18Buy
14.54Buy
MA50
14.44Buy
14.92Buy
MA100
16.46Sell
16.35Sell
MA200
18.99Sell
19.05Sell
Prothena’s (PRTA) 10-Day exponential moving average is 14.91, while Prothena’s (PRTA) share price is $15.96, making it a Buy.
Prothena’s (PRTA) 100-Day exponential moving average is 16.35, while Prothena’s (PRTA) share price is $15.96, making it a Sell.
Prothena’s (PRTA) stock price is $15.96 and Prothena’s (PRTA) 50-day simple moving average is 14.44, creating a Buy signal.
Prothena’s (PRTA) stock price is $15.96 and Prothena’s (PRTA) 100-day simple moving average is 16.46, creating a Sell signal.
Prothena’s (PRTA) stock price is $15.96 and Prothena’s (PRTA) 200-day simple moving average is 18.99, creating a Sell signal.

Prothena (PRTA) Technical Indicators

Jan 29, 2025, 08:42 PM
Name
Value
Implied Action
RSI (14)
60.83
Neutral
STOCH (9,6)
84.85
Sell
STOCHRSI (14)
85.59
Sell
MACD (12,26)
0.26
Sell
ADX (14)
19.51
Buy
Williams %R
-16.00
Sell
CCI (14)
150.86
Sell
ATR (14)
1.05
-
Ultimate Oscillator
58.89
Neutral
ROC
21.37
Buy
Prothena’s (PRTA) Relative Strength Index (RSI) is 60.83, creating a Neutral signal.
Prothena’s (PRTA) Trend Strength Indicator (ADX) is 19.51, creating a Buy signal.
Prothena’s (PRTA) Commodity Channel Index (CCI) is 150.86, creating a Sell signal.
Prothena’s (PRTA) Price Rate of Change (ROC) is 21.37, creating a Buy signal.

FAQ

Is PRTA a Buy, Hold, or Sell?
Based on PRTA’s technical indicators, PRTA is a Hold.
    What is PRTA’s RSI (14)?
    PRTA’s RSI (14) is 60.83, which suggests PRTA is a Neutral.
      What is PRTA’s MACD?
      PRTA’s MACD is 0.26, which suggests PRTA is a Sell.
        What is PRTA’s 5-day moving average?
        PRTA’s 5-day moving average is 15.51, which suggests PRTA is a Buy.
          What is PRTA’s 20-day moving average?
          PRTA 20-day moving average is 14.18, which suggests PRTA is a Buy.
            What is PRTA’s 50-day moving average?
            PRTA’s 50-day moving average is 14.44, which suggests PRTA is a Buy.
              What is PRTA’s 200-day moving average?
              PRTA’s 200-day moving average is 18.99, which suggests PRTA is a Sell.
                What is PRTA’s Williams % R (14)?
                PRTA’s Williams % R (14) is -16.00, which suggests PRTA is a Sell.
                  What is PRTA’s CCI (14)?
                  PRTA’s CCI (14) is 150.86, which suggests PRTA is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis